Literature DB >> 7672488

Long-term instability of fasting plasma glucose predicts mortality in elderly NIDDM patients: the Verona Diabetes Study.

M Muggeo1, G Verlato, E Bonora, F Ciani, P Moghetti, R Eastman, G Crepaldi, R de Marco.   

Abstract

The aim of this study was to evaluate whether long-term glucose control, as assessed by fasting plasma glucose determinations during 3 years, is a predictor of all-cause mortality in elderly NIDDM patients. Five hundred and sixty-six NIDDM patients attending the Verona Diabetes Clinic, aged 75 years and over, were followed-up from 1 January 1987 to 31 December 1991 to assess all-cause mortality. From their clinical records all fasting plasma glucose determinations available for the years 1984 to 1986 were collected and analysed. Patients were grouped in tertiles according to mean (M-FPG), coefficient of variation (CV-FPG) and trend over time (slope, S-FPG) of fasting plasma glucose during the period of retrospective evaluation. Mortality was assessed by observed/expected ratios, univariate Kaplan-Meier survival analysis and multivariate Poisson regression model. By 31 December 1991, 61 men and 127 women had died. Increased observed/expected ratios were found in women from the top M-FPG tertile, in patients (men and women) from the top CV-FPG tertile and in patients with a S-FPG less than -0.30 mmol/l per year (lowest tertile). Patients in the lowest tertile of CV-FPG and in the middle tertile of S-FPG had a reduced mortality risk. Kaplan-Meier survival analysis indicated that patients with high CV-FPG as well as those in tertiles I and III of S-FPG (i.e., those with a definitely negative or definitely positive slope) had an increased probability of dying, without any significant differences between the three tertiles of M-FPG.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7672488     DOI: 10.1007/bf00401838

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  24 in total

1.  The Oxford Community Diabetes Study: evidence for an increase in the prevalence of known diabetes in Great Britain.

Authors:  H A Neil; W Gatling; H M Mather; A V Thompson; M Thorogood; G H Fowler; R D Hill; J I Mann
Journal:  Diabet Med       Date:  1987 Nov-Dec       Impact factor: 4.359

2.  Prevalence of fasting hyperglycemia and known non-insulin-dependent diabetes mellitus classified by plasma C-peptide: Fredericia survey of subjects 60-74 yr old.

Authors:  E M Damsgaard; O K Faber; A Frøland; A Green; M Hauge; N V Holm; S Iversen
Journal:  Diabetes Care       Date:  1987 Jan-Feb       Impact factor: 19.112

3.  Daily insulin dose as a predictor of macrovascular disease in insulin treated non-insulin-dependent diabetics.

Authors:  H U Janka; A G Ziegler; E Standl; H Mehnert
Journal:  Diabete Metab       Date:  1987-07

4.  UK Prospective Diabetes Study (UKPDS). VIII. Study design, progress and performance.

Authors: 
Journal:  Diabetologia       Date:  1991-12       Impact factor: 10.122

5.  Glycated haemoglobin, plasma glucose and diabetic retinopathy: cross-sectional and prospective analyses.

Authors:  Q Z Liu; D J Pettitt; R L Hanson; M A Charles; R Klein; P H Bennett; W C Knowler
Journal:  Diabetologia       Date:  1993-05       Impact factor: 10.122

6.  Diabetes mellitus, impaired glucose tolerance and mortality among elderly men: the Finnish cohorts of the Seven Countries Study.

Authors:  J H Stengård; J Tuomilehto; J Pekkanen; P Kivinen; E Kaarsalo; A Nissinen; M J Karvonen
Journal:  Diabetologia       Date:  1992-08       Impact factor: 10.122

7.  The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus.

Authors:  P Reichard; B Y Nilsson; U Rosenqvist
Journal:  N Engl J Med       Date:  1993-07-29       Impact factor: 91.245

8.  The prevalence of diabetes in elderly people.

Authors:  S C Croxson; A C Burden; M Bodington; J L Botha
Journal:  Diabet Med       Date:  1991-01       Impact factor: 4.359

9.  Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group.

Authors: 
Journal:  Diabetes       Date:  1979-12       Impact factor: 9.461

10.  A population-based study of the incidence of complications associated with type 2 diabetes in the elderly.

Authors:  D L Cohen; H A Neil; M Thorogood; J I Mann
Journal:  Diabet Med       Date:  1991-12       Impact factor: 4.359

View more
  8 in total

Review 1.  Endothelial Dysfunction and Platelet Hyperactivation in Diabetic Complications Induced by Glycemic Variability.

Authors:  Ye Huang; Long Yue; Jiahuang Qiu; Ming Gao; Sijin Liu; Jingshang Wang
Journal:  Horm Metab Res       Date:  2022-07-14       Impact factor: 2.788

2.  Hyperglycemia increases the risk of death in extremely preterm baboons.

Authors:  Cynthia L Blanco; Lisa L McGill-Vargas; Donald McCurnin; Amy R Quinn
Journal:  Pediatr Res       Date:  2012-12-07       Impact factor: 3.756

3.  Sleep apnea, sleep disturbance, and fasting glucose variability: a pilot study.

Authors:  Patrizio Tatti; Felice Strollo; Desiderio Passali
Journal:  J Diabetes Sci Technol       Date:  2013-05-01

4.  Glycemic variability: both sides of the story.

Authors:  Antonio Ceriello; Eric S Kilpatrick
Journal:  Diabetes Care       Date:  2013-08       Impact factor: 19.112

5.  Association of Postbreakfast Triglyceride and Visit-to-Visit Annual Variation of Fasting Plasma Glucose with Progression of Diabetic Nephropathy in Patients with Type 2 Diabetes.

Authors:  Kaori Kitaoka; Akiko Takenouchi; Ayaka Tsuboi; Keisuke Fukuo; Tsutomu Kazumi
Journal:  J Diabetes Res       Date:  2016-11-15       Impact factor: 4.011

6.  Protective effect of metformin against retinal vein occlusions in diabetes mellitus - A nationwide population-based study.

Authors:  Tai-Chi Lin; De-Kuang Hwang; Chih-Chien Hsu; Chi-Hsien Peng; Mong-Lien Wang; Shih-Hwa Chiou; Shih-Jen Chen
Journal:  PLoS One       Date:  2017-11-14       Impact factor: 3.240

7.  Glycemic Variability in Diabetes Increases the Severity of Influenza.

Authors:  Rebecca J Marshall; Pornthida Armart; Katina D Hulme; Keng Yih Chew; Alexandra C Brown; Philip M Hansbro; Conor J Bloxham; Melanie Flint; Katharina Ronacher; Helle Bielefeldt-Ohmann; Linda A Gallo; Kirsty R Short
Journal:  mBio       Date:  2020-03-24       Impact factor: 7.867

8.  Visit-to-visit variability of glycemia and vascular complications: the Hoorn Diabetes Care System cohort.

Authors:  Roderick C Slieker; Amber A W H van der Heijden; Giel Nijpels; Petra J M Elders; Leen M 't Hart; Joline W J Beulens
Journal:  Cardiovasc Diabetol       Date:  2019-12-12       Impact factor: 9.951

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.